Oklahoma 2023 Regular Session

Oklahoma Senate Bill SB228 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2
3	3
4	4	Req. No. 1436 Page 1 1
5	5	2
6	6	3
7	7	4
8	8	5
9	9	6
10	10	7
11	11	8
12	12	9
13	13	10
14	14	11
15	15	12
16	16	13
17	17	14
18	18	15
19	19	16
20	20	17
21	21	18
22	22	19
23	23	20
24	24	21
25	25	22
26	26	23
27	27	24
28	28	1
29	29	2
30	30	3
31	31	4
32	32	5
33	33	6
34	34	7
35	35	8
36	36	9
37	37	10
38	38	11
39	39	12
40	40	13
41	41	14
42	42	15
43	43	16
44	44	17
45	45	18
46	46	19
47	47	20
48	48	21
49	49	22
50	50	23
51	51	24
52	52
53	53	STATE OF OKLAHOMA
54	54
55	55	1st Session of the 59th Legislature (2023)
56	56
57	57	SENATE BILL 228 By: Standridge
58	58
59	59
60	60
61	61
62	62
63	63	AS INTRODUCED
64	64
65	65	An Act relating to the practice of pharma cy; amending
66	66	59 O.S. 2021, Section 353.30 , which relates to
67	67	agreements; modifying term; authorizing pharmacist to
68	68	enter into collaborative practice agreements;
69	69	directing promulgation of ru les; defining term; and
70	70	providing an effective date .
71	71
72	72
73	73
74	74
75	75	BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
76	76	SECTION 1. AMENDATORY 59 O.S. 2021, Section 353.30, is
77	77	amended to read as follows:
78	78	Section 353.30. A. The use of collaborative practice
79	79	agreements in the practice of pharmacy shall be acceptable within
80	80	the rules promulgated by the State Board of Pharmacy an d in
81	81	consultation with the State Board of Medical Licensure and
82	82	Supervision and the State Board of Osteopathic Examiners . A
83	83	pharmacist may enter into a collaborative practice agreement with
84	84	one or more practitioners licensed in this state .
85	85	B. The Board shall develop and prepare permanent rules relating
86	86	to collaborative practice agreements including, but not limited to,
87	87	training requirements and administration of immunizations and
88	88
89	89
90	90	Req. No. 1436 Page 2 1
91	91	2
92	92	3
93	93	4
94	94	5
95	95	6
96	96	7
97	97	8
98	98	9
99	99	10
100	100	11
101	101	12
102	102	13
103	103	14
104	104	15
105	105	16
106	106	17
107	107	18
108	108	19
109	109	20
110	110	21
111	111	22
112	112	23
113	113	24
114	114	1
115	115	2
116	116	3
117	117	4
118	118	5
119	119	6
120	120	7
121	121	8
122	122	9
123	123	10
124	124	11
125	125	12
126	126	13
127	127	14
128	128	15
129	129	16
130	130	17
131	131	18
132	132	19
133	133	20
134	134	21
135	135	22
136	136	23
137	137	24
138	138
139	139	therapeutic injections in consultatio n within the State Board of
140	140	Medical Licensure and S upervision and the State Board of Osteopathic
141	141	Examiners.
142	142	C. A pharmacist who has completed a requisite course of
143	143	training as approved by the Board in consultation with the State
144	144	Board of Medical Licensure and Supervision and the State Board of
145	145	Osteopathic Examiners may administer therapeutic injections on
146	146	orders from a licensed prescriber, and may administer immunizations
147	147	that have been approved or authorized by the Food an d Drug
148	148	Administration without a p atient-specific prescription, standing
149	149	order or similar arrangement.
150	150	D. As used in this section, “collaborative practice agre ement”
151	151	means a formal agreement in which a licensed practitioner makes a
152	152	diagnosis, supervises patient care, and refers patients t o a
153	153	pharmacist under a protocol that allows the pha rmacist to perform
154	154	specific patient care functio ns including, but not limited to,
155	155	administration of immunizations and therapeutic injections .
156	156	SECTION 2. This act shall become effective Nov ember 1, 2023.
157	157
158	158	59-1-1436 DC 1/9/2023 6:14:14 PM